Plasma concentration of angiopoietin-1, angiopoietin-2 and Tie-2 in cervical cancer

European Journal of Gynaecological Oncology

Volumn 30, Issue 6, 2009, Pages 646-649

  Kopczynska E ^a   Makarewicz, R ^a   Biedka, M ^a   Kaczmarczyk, A ^b   Kardymowicz, H ^b   Tyrakowski, T ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

Author keywords

Angiopoietins; Cervical cancer

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; FEMALE; HUMANS; NEOPLASM STAGING; RECEPTOR, TIE-2; UTERINE CERVICAL NEOPLASMS;

EID: 70949106271     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bach F., Uddin F.J., Burke D.: "Angiopoietins in malignancy". EJSO, 2007, 33, 7.
2. Makinde T., Agrawal D.K.: "Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease". J. Cell. Mol. Med., 2008, 12, 810. (Pubitemid 351718065)
3. Martin V., Liu D., Fueyo J., Gomez-Mainzano C.: "Tie2: a journey from normal angiogenesis to cancer and beyond". Histol. Histopathol., 2008, 23, 773. (Pubitemid 351552362)
4. Eklund L., Olsen B.R.: "Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling". Exp. Cell. Res., 2006, 312, 630. (Pubitemid 43290339)
5. Shim W.S.N., Ho I.A.W., Wong P.E.H.: "Angiopoietin: A Tie(d) balance in tumor angiogenesis". Mol. Cancer Res., 2007, 5, 655.
6. Hanahan D., Folkman J.: "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis". Cell, 1996, 86, 353. (Pubitemid 26272076)
7. Tait C.R., Jones P.F.: "Angiopoietins in tumours: the angiogenic switch". J. Pathol., 2004, 204, 1.
8. Naumov G.N., Folkman J., Straume O., Akslen L.A.: "Tumor-vascular interactions and tumor dormancy". APMIS, 2008, 116, 569.
9. Nakayama T., Hatachi G., Wen Ch.Y., Yoshizaki A., Yamazumi K., Niino D. et al.: "Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors". World J. Gastroenterol., 2005, 11, 964. (Pubitemid 40347746)
10. Chung Y.C., Hou Y.C., Chang C.N., Hseu T.H.: "Expression and prognostic significance of angiopoietin in colorectal carcinoma". J. Surg. Oncol., 2006, 94, 631.
11. Ahmad S.A., Liu W., Jung Y.D., Fan E, Reinmuth N., Bucana C.D. et al.: "Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis". Cancer, 2001, 92, 1138. (Pubitemid 32861662)
12. Moon W.S., Rhyu K.H., Kang M.J., Lee D.G., Yu H.C., Yeum J.H. et al.: "Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?". Mod. Pathol., 2003, 16, 552.
13. Reiss Y., Machein M.R., Plate K.H.: "The role of angiogenesis during angiogenesis in gliomas". Brain Pathol., 2005, 15, 311.
14. Koga K., Todaka T., Morioka M., Hamada J., Kai Y., Yano S. et al.: "Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis". Cancer Res., 2001, 61, 6248. (Pubitemid 32762564)
15. Stratmann A., Risau W., Plate K.H.: "Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis". Am. J. Pathol., 1998, 153, 1459. (Pubitemid 28509902)
16. Hayes A.J., Huang W.Q., Yu J., Maisonpierre P.C., Liu A., Kern F.G. et al.: "Expression and function of angiopoietin-1 in breast cancer". Br. J. Cancer, 2000, 83, 1154. (Pubitemid 30812323)
17. Guo P., Imanishi Y., Cackowski F.C., Jarzynka M.J., Tao H.Q., Nishikawa R. et al.: "Up-regulation of angiopoietin-2, matrix metalloproteinase-2, membrane type 1 metalloproteinase, and laminin 5 g 2 correlates with the invasiveness of human glioma". Am. J. Pathol., 2005, 166, 877. (Pubitemid 40315644)
18. Eggert A., Ikegaki N., Kwiatkowski J., Zhao H., Brodeur G.M., Himelstein B.P.: "High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas". Clin. Cancer Res., 2000, 6, 1900. (Pubitemid 30305088)
19. Sfiligoi Ch., De Luca A., Cascone I., Sorbello V., Fuso L., Ponzone R. et al.: "Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival". Int. J. Cancer, 2003, 103, 466. (Pubitemid 36020220)
20. Imanishi Y., Hu B., Jarzynka M.J., Guo P., Elishaev E., Bar-Joseph I. et al.: "Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway". Cancer Res., 2007, 67, 4254. (Pubitemid 46815072)
21. Tanaka F., Ishikawa S., Yanagihara K., Miyahara R., Kawano Y., Li M. et al.: "Expression of angiopoietins and its clinical significance in non-small cell lung cancer". Cancer Res., 2002, 62, 7124. (Pubitemid 35424109)
22. Lind A.J., Wikstrom P., Granfors T., Egevad L., Stattin P., Bergh A.: "Angiopoietin-2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer". Prostate, 2005, 62, 394. (Pubitemid 40224144)
23. Zhong-Lin Z., Zhi-Su L., Quan S.: "Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma". World J. Gastroenterol., 2006, 12, 4241.
24. Hata K., Nakayama K., Fujiwaki R., Katabuchi H., Okamura H., Miyazaki K.: "Expression of the angiopoietin-1, angiopoietin-2, Tie-2, and vascular endothelial growth factor gene in epithelial ovarian cancer". Gynaecol. Oncol., 2004, 93, 215. (Pubitemid 38429573)
25. Caine G.J., Blann A.D., Stonelake P.S., Ryan P., Lip G.Y.H.: "Plasma angiopoietin-1, angiopoietin-2 and Tie-2 breast and prostate cancer: a comparison with VEGF and Flt-1". Eur. J. Clin. Invest., 2003, 33, 883. (Pubitemid 37215044)
26. Park J.H., Park K.J., Kim Y.S., Sheen S.S., Lee K.S., Lee H.N. et al.: "Serum angiopoietin-2 as a clinical marker for lung cancer". Chest, 2007, 132, 200.
27. Chin K.F., Greenman J., Reusch P., Gardiner E., Marme D., Monson J.: "Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections". Anticancer Res., 2004, 24, 2353. (Pubitemid 39172191)
28. Chin K.F., Greenman J., Reusch P., Gardiner E., Marme D., Monson J.: "Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence". Eur. J. Surg. Oncol., 2003, 29, 497. (Pubitemid 37009966)
29. Fiedler U., Scharpfenecker M., Koidl S., Hegen A., Grunow V., Schmidt J.M. et al.: "The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies". Blood, 2004, 103, 4150. (Pubitemid 38685356)